Australia markets open in 8 hours 56 minutes

AstraZeneca PLC (AZN.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
8,682.00+65.00 (+0.75%)
As of 3:49PM BST. Market open.
Full screen
Previous close8,617.00
Bid8,682.00 x 0
Ask8,684.00 x 0
Day's range8,593.00 - 8,735.22
52-week range6,499.80 - 8,811.00
Avg. volume3,350,579
Market cap134.495B
Beta (5Y monthly)0.19
PE ratio (TTM)41.30
EPS (TTM)210.20
Earnings date12 Nov 2021
Forward dividend & yield2.02 (2.32%)
Ex-dividend date12 Aug 2021
1y target est131.53
  • Editor's pick
    Yahoo Finance Video

    If we’re to get out of this pandemic it’ll require a global response: Doctor

    Dr. Cedric Dark, Assistant Professor at Baylor College of Medicine & Board Member with Doctors for America, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.

  • Bloomberg

    U.S. Workers File Vaccine Suit; Novavax Request: Virus Update

    (Bloomberg) -- A group of federal workers and contractors filed suit against the U.S. government over its Covid-19 mandates, challenging President Joe Biden’s executive order requiring staff to be vaccinated.Most Read from BloombergIstanbul Turns Taps on Old Fountains, Joining Global Push for Free DrinksIn Paris, the Wrapped Arc de Triomphe Is a Polarizing PackageHow the Child Care Crisis Became a Global Economic FiascoThe Global Housing Market Is Broken, and It’s Dividing Entire CountriesBerlin

  • The Telegraph

    AstraZeneca bets on RNA technology used in rival Covid vaccines

    AstraZeneca has taken a sizeable stake in an Imperial College spinout that develops drugs based on the RNA technology used in Covid vaccines made by two major rivals.